Literature DB >> 21646384

GnRH antagonists are safer than agonists: an update of a Cochrane review.

Hesham G Al-Inany1, Mohamed A F M Youssef, Mohamed Aboulghar, Frank Broekmans, Monique Sterrenburg, Janine Smit, Ahmed M Abou-Setta.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21646384     DOI： 10.1093/humupd/dmr004

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN： 1355-4786            Impact factor:   15.610


× No keyword cloud information.
  22 in total

1.  Fifteen year follow-up of embryos cryopreserved in cancer patients for fertility preservation.

Authors:  J Barcroft; N Dayoub; K J Thong
Journal:  J Assist Reprod Genet       Date:  2013-07-09       Impact factor: 3.412

2.  Multiorgan failure associated with severe ovarian hyperstimulation syndrome due to inadequate protocol optimisation: a rare but avoidable complication.

Authors:  Lorraine Sheena Kasaven; Anastasia Goumenou; Kenneth Adegoke
Journal:  BMJ Case Rep       Date:  2018-03-05

3.  GnRH antagonist for patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer in fresh cycles.

Authors:  Xiang-Hong Zhai; Ping Zhang; Feng-Xia Wu; An-Cong Wang; Pei-Shu Liu
Journal:  Exp Ther Med       Date:  2017-04-05       Impact factor: 2.447

Review 4.  Comparison of different stimulation protocols used in in vitro fertilization: a review.

Authors:  Deekshya Shrestha; Xiaolin La; Huai L Feng
Journal:  Ann Transl Med       Date:  2015-06

5.  Comparison of follicular fluid amphiregulin and EGF concentrations in patients undergoing IVF with different stimulation protocols.

Authors:  Nana Liu; Yanmin Ma; Rong Li; Hongyan Jin; Min Li; Xiang Huang; Huai L Feng; Jie Qiao
Journal:  Endocrine       Date:  2012-06-08       Impact factor: 3.633

6.  A comparative study on oxidative and antioxidative markers of serum and follicular fluid in GnRH agonist and antagonist cycles.

Authors:  Ebru Celik; Onder Celik; Banu Kumbak; Ercan Yilmaz; Ilgin Turkcuoglu; Yavuz Simsek; Abdullah Karaer; Yagmur Minareci; Elif Ozerol; Kevser Tanbek
Journal:  J Assist Reprod Genet       Date:  2012-08-12       Impact factor: 3.412

7.  Assessing the optimal dose for Cetrorelix in Chinese women undergoing ovarian stimulation during the course of IVF-ET treatment.

Authors:  Qiaohong Lai; Jun Hu; Dan Zeng; Juan Hu; Fuying Cai; Fei Yang; Cai Chen; Xiaoyu He; Ping Yang; Qilin Yu; Shu Zhang; Jun-Fa Xu; Cong-Yi Wang
Journal:  Am J Transl Res       Date:  2013-12-01       Impact factor: 4.060

8.  Effects of multicycle gonadotropin-releasing hormone antagonist protocols on oxidative stress of follicular fluid and ovarian granulosa cells.

Authors:  Yucong Ma; Zhiming Zhao; Guimin Hao; Na Cui; Yanli Fan; Yucong Cao; Zhanwang Tan; Jingran Geng; Lijie Fan; Huilan Du; Bulang Gao
Journal:  Hum Cell       Date:  2021-05-08       Impact factor: 4.174

9.  Spontaneous bacterial peritonitis complicating ovarian hyperstimulation syndrome-related ascites.

Authors:  Leandro Utino Taniguchi; Cláudia Gennari Lacerda Jorge; Lucas Fernandes de Oliveira
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

10.  Cumulus cells gene expression profiling in terms of oocyte maturity in controlled ovarian hyperstimulation using GnRH agonist or GnRH antagonist.

Authors:  Rok Devjak; Klementina Fon Tacer; Peter Juvan; Irma Virant Klun; Damjana Rozman; Eda Vrtačnik Bokal
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.